News | April 28, 2024
Apollo HealthCo to raise Rs. 2,475 crore from Advent International
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
New Board of Directors and management team at Suven Pharma also appointed
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)